ORGO Q1 2017 Earnings — Organogenesis Holdings Inc. Revenue & Financial Results | Market Cap Arena

ORGOOrganogenesis Holdings Inc.

$338M

Q1 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0

Gross Profit

-$218,648

Operating Income

-$218,648

Net Income

$140,863

EPS (Diluted)

$-0.02

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$126,290

Free Cash Flow

-$126,290

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$311M

Total Liabilities

$11M

Stockholders' Equity

$300M

Cash & Equivalents

$486,200

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$218,648	-$15,550	-1306.1%
Operating Income	-$218,648	-$15,550	-1306.1%
Net Income	$140,863	-$15,550	+1005.9%